Zinpentraxin Alfa Reduces Myelofibrosis in a JAK2-V617F Mouse Model of Myeloproliferative Neoplasms

This poster, shown at the American Society of Hematology 2023 Annual Meeting with Roche and the University of Basel, delves into the impact of rhPTX2 immunotherapy on mouse Myeloproliferative neoplasms. It leverages insights from plasma proteome profiling generated with our TrueDiscovery^® platform.